Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis

Conditions:   Anti-MDA5 Antibody-positive Dermatomyositis;   Respiratory Injury Interventions:   Drug: triple therapy;   Drug: dual-therapy Sponsor:   The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials